Topical ocular administration of DPP-IV inhibitors: a new approach for treating diabetes-induced retinal neurodegeneration

Neural Regen Res. 2024 Apr;19(4):713-714. doi: 10.4103/1673-5374.353492.

¹ Diabetes and Metabolism Research Unit, Vall d'Hebron Research Institute (VHIR); Department of Medicine, Autonomous University of Barcelona, Barcelona; Centro de Investigacioìn Biomeìdica en Red de Diabetes y Enfermedades Metaboìlicas Asociadas (CIBERDEM), Instituto de Salud Carlos III (ICSIII), Madrid, Spain.

No abstract available